Drug Trial Radar · NCT06346509
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: Apr 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
156
Actual
Start
Apr 8, 2024
Primary completion
Dec 27, 2025
Study completion Jan 20, 2026
Sponsor
- Lead sponsor
- Portal Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation of the administration of PORT-77 in healthy adult participants.
Conditions
- Healthy Adult Participants
Interventions
PORT-77Drug
Healthy adult participants will receive PORT 77.
PlaceboDrug
Healthy adult participants will receive matching placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of incidence and severity of adverse events (AEs) as a measure of safety and tolerability of PORT-77 (Part I)Time frame: Day 8
- Number of incidence and severity of AEs as a measure of safety and tolerability of PORT-77 (Part II and III)Time frame: Day 21
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion
Tempe, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.